As part of the Effervescence conference, the Centre Québécois d'Innovation en Biotechnologie (CQIB) announced a contribution of $420,000 to seven startups for the clinical data validation of new medical technologies.
Read More
As part of the Effervescence conference, the Centre Québécois d'Innovation en Biotechnologie (CQIB) announced a contribution of $420,000 to seven startups for the clinical data validation of new medical technologies.
Read More